These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 13347046)

  • 1. [Examination of steroids in therapy with N'-sulfanilyl-N2-N-butylcarbamid (nadisan)].
    RAUSCH-STROOMANN JG; SAUER H
    Klin Wochenschr; 1956 Jul; 34(25-26):707-8. PubMed ID: 13347046
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preliminary experiences with the sulfonamide nadisan in therapy of diabetes].
    BROGLIE M; VOSS G; BERG EG; RUHLING O
    Medizinische; 1956 Apr; (17):656-9. PubMed ID: 13321484
    [No Abstract]   [Full Text] [Related]  

  • 3. BZ 55 in diabetes.
    MCKENZIE JM; MARSHALL PB; STOWERS JM; HUNTER RB
    Br Med J; 1956 Aug; 2(4990):448-51. PubMed ID: 13342510
    [No Abstract]   [Full Text] [Related]  

  • 4. The value of BZ 55 in control of diabetes.
    MURRAY I; WANG I
    Br Med J; 1956 Aug; 2(4990):452-4. PubMed ID: 13342512
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypoglycaemic sulphonamides in treatment of diabetes.
    WALKER G; LEESE WL; NABARRO JD
    Br Med J; 1956 Aug; 2(4990):451-2. PubMed ID: 13342511
    [No Abstract]   [Full Text] [Related]  

  • 6. Trial of an oral hypoglycaemic agent in diabetes.
    WOLFF FW; STEWART GA; CROWLEY MF; BLOOM A
    Br Med J; 1956 Aug; 2(4990):440-5. PubMed ID: 13342508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Critical study of the mechanism of action of the oral anti-diabetic agent, nadisan].
    FRAENKEL KA; SCHULZ K
    Dtsch Med J; 1956 Apr; 7(8):209-14. PubMed ID: 13344175
    [No Abstract]   [Full Text] [Related]  

  • 8. [Severe hypoglycemic reactions during peroral treatment of diabetes with N1-sulfanilyl-n-2-n-butylcarbamid (BZ 55)].
    BENDFELDT E; OTTO H
    Munch Med Wochenschr; 1956 Aug; 98(35):1136-7. PubMed ID: 13369451
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of the peroral antidiabetic drug, N1-sulfanilyl-N'-butyl urea (nadisan, invenol) on diabetes mellitus in man].
    KLOTZBUCHER E
    Z Gesamte Inn Med; 1956 Dec; 11(23):1075-81. PubMed ID: 13423436
    [No Abstract]   [Full Text] [Related]  

  • 10. ORAL HYPOGLYCEMIC agents.
    Nutr Rev; 1956 Jul; 14(7):203-4. PubMed ID: 13335036
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new anti-diabetes principle; results of clinical research].
    FRANKE H; FUCHS J
    Dtsch Med Wochenschr; 1955 Oct; 80(40):1449-52. PubMed ID: 13261731
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trial of the new oral hypoglycaemic agent BZ 55.
    HUNT JA; OAKLEY W; LAWRENCE RD
    Br Med J; 1956 Aug; 2(4990):445-8. PubMed ID: 13342509
    [No Abstract]   [Full Text] [Related]  

  • 13. Tolbutamide in treatment of diabetes mellitus.
    BUTTERFIELD WJ; FRY IK; HARDWICK C; HOLLING HE
    Br Med J; 1957 Aug; 2(5040):325-7. PubMed ID: 13446469
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism of action of the sulfonylureas in diabetes mellitus.
    LEVINE R; SOBEL GW
    Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633
    [No Abstract]   [Full Text] [Related]  

  • 15. New orally effective adjuvants in the management of diabetes mellitus.
    O'DONOVAN CJ
    J Chronic Dis; 1956 Dec; 4(6):635-43. PubMed ID: 13376693
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic studies with the arylsulfonylureas.
    KUHL WJ
    Diabetes; 1957; 6(1):61; discussion, 62. PubMed ID: 13397426
    [No Abstract]   [Full Text] [Related]  

  • 17. Current status of aryl sulfonylureas in treatment of diabetes mellitus.
    DAVIDSON JW; UNGER RH
    J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of the mechanism of action of sulfonylurea derivatives.
    GOLDNER MG; LAZARUS SS; VOLK BW; WEISENFELD S
    Diabetes; 1957; 6(1):53-4. PubMed ID: 13397423
    [No Abstract]   [Full Text] [Related]  

  • 19. Tolbutamide in diabetes; some clinical and biochemical studies.
    CROWLEY MF; WOLFF FW; BLOOM A
    Br Med J; 1957 Aug; 2(5040):327-31. PubMed ID: 13446470
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experiences with carbutamide, an orally given hypoglycemic agent; preliminary report.
    RIDOLFO AS; KIRTLEY WR
    J Am Med Assoc; 1956 Apr; 160(15):1285-8. PubMed ID: 13306540
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.